Fungal Infections in Immunocompromised Hosts
| dc.contributor.author | Kontoyiannis, Dimitrios P. | * |
| dc.contributor.author | Slavin, Monica | * |
| dc.date.accessioned | 2021-02-11T14:13:43Z | |
| dc.date.available | 2021-02-11T14:13:43Z | |
| dc.date.issued | 2019 | * |
| dc.date.submitted | 2019-04-05 10:34:31 | * |
| dc.identifier | 32835 | * |
| dc.identifier.uri | https://directory.doabooks.org/handle/20.500.12854/48211 | |
| dc.description.abstract | This book is a printed edition of the Special Issue Fungal Infections in Immunocompromised Hosts that was published in JoF | * |
| dc.language | English | * |
| dc.subject | QH301-705.5 | * |
| dc.subject | QR1-502 | * |
| dc.subject | Q1-390 | * |
| dc.subject.classification | thema EDItEUR::P Mathematics and Science::PS Biology, life sciences | en_US |
| dc.subject.other | toxicity | * |
| dc.subject.other | risk assessment | * |
| dc.subject.other | species complex | * |
| dc.subject.other | galactomannan | * |
| dc.subject.other | taxonomy | * |
| dc.subject.other | Aspergillus PCR | * |
| dc.subject.other | candidemia | * |
| dc.subject.other | adaptive immunity | * |
| dc.subject.other | fungal immunity | * |
| dc.subject.other | T2 Candida | * |
| dc.subject.other | anti-fungal agents | * |
| dc.subject.other | innate immunity | * |
| dc.subject.other | antifungal stewardship | * |
| dc.subject.other | Immunotherapy | * |
| dc.subject.other | Candida meningoencephalitis | * |
| dc.subject.other | liposomal amphotericin B | * |
| dc.subject.other | anidulafungin | * |
| dc.subject.other | liver disease | * |
| dc.subject.other | invasive mold disease | * |
| dc.subject.other | T2Candida | * |
| dc.subject.other | AIDS | * |
| dc.subject.other | (1?3)-?-d-glucan | * |
| dc.subject.other | literature review | * |
| dc.subject.other | yeast | * |
| dc.subject.other | hepatic impairment | * |
| dc.subject.other | prediction models | * |
| dc.subject.other | IRIS | * |
| dc.subject.other | invasive aspergillosis | * |
| dc.subject.other | antifungal agent | * |
| dc.subject.other | TNF inhibitors | * |
| dc.subject.other | Aspergillus fumigatus | * |
| dc.subject.other | fungal nomenclature | * |
| dc.subject.other | micafungin | * |
| dc.subject.other | non-culture-based diagnostics | * |
| dc.subject.other | PCR | * |
| dc.subject.other | paracoccidioidomycosis | * |
| dc.subject.other | Candida auris | * |
| dc.subject.other | multidrug resistance | * |
| dc.subject.other | subcutaneous mycoses | * |
| dc.subject.other | risk score | * |
| dc.subject.other | mycoses of implantation | * |
| dc.subject.other | Sporothrix brasiliensis | * |
| dc.subject.other | antifungal resistance | * |
| dc.subject.other | immunocompromised hosts | * |
| dc.subject.other | Sporothrix schenckii | * |
| dc.subject.other | Aspergillus | * |
| dc.subject.other | fungus | * |
| dc.subject.other | cell therapy | * |
| dc.subject.other | MALDI-ToF MS | * |
| dc.subject.other | lateral flow | * |
| dc.subject.other | phylogenetics | * |
| dc.subject.other | hematological malignancy | * |
| dc.subject.other | candidiasis | * |
| dc.subject.other | antifungal drug | * |
| dc.subject.other | hematological malignancies | * |
| dc.subject.other | mycoses | * |
| dc.subject.other | invasive fungal infections | * |
| dc.subject.other | lymphoma | * |
| dc.subject.other | kidney transplant | * |
| dc.subject.other | immune reconstitution inflammatory syndrome | * |
| dc.subject.other | mechanisms of antifungal resistance | * |
| dc.subject.other | fungal infections | * |
| dc.subject.other | cytokine therapy | * |
| dc.subject.other | sporotrichosis | * |
| dc.subject.other | beta-d-glucan | * |
| dc.subject.other | invasive fungal infection | * |
| dc.subject.other | HIV | * |
| dc.subject.other | cat-transmitted sporotrichosis | * |
| dc.subject.other | aspergillosis | * |
| dc.subject.other | cancer | * |
| dc.subject.other | prognostic risk model | * |
| dc.title | Fungal Infections in Immunocompromised Hosts | * |
| dc.type | book | |
| oapen.identifier.doi | 10.3390/books978-3-03897-717-9 | * |
| oapen.relation.isPublishedBy | 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 | * |
| oapen.relation.isbn | 9783038977162 | * |
| oapen.pages | 212 | * |
| oapen.edition | 1st | * |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||

